Prognostic value of <i>KRAS</i> mutations, <i>TP53</i> mutations and PD-L1 expression among lung adenocarcinomas treated with immunotherapy.

Tønnesen, Ea Maria Tønning; Stougaard, Magnus; Meldgaard, Peter; Lade-Keller, Johanne

Prognostic value of KRAS mutations, TP53 mutations and PD-L1 expression among lung adenocarcinomas treated with immunotherapy.

Tønnesen, Ea Maria Tønning; Stougaard, Magnus; Meldgaard, Peter; Lade-Keller, Johanne.

Afiliación

Tønnesen EMT; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark Ea@pressefoto.dk.
Stougaard M; Department of Pathology, Viborg Regional Hospital, Viborg, Denmark.
Meldgaard P; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
Lade-Keller J; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

J Clin Pathol ; 77(1): 54-60, 2023 Dec 14.

Article en En | MEDLINE | ID: mdl-36410939

Asunto(s)

Adenocarcinoma del Pulmón; Carcinoma de Pulmón de Células no Pequeñas; Neoplasias Pulmonares; Humanos; Neoplasias Pulmonares/terapia; Neoplasias Pulmonares/tratamiento farmacológico; Carcinoma de Pulmón de Células no Pequeñas/genética; Pronóstico; Antígeno B7-H1/genética; Antígeno B7-H1/metabolismo; Proteínas Proto-Oncogénicas p21(ras)/genética; Estudios Retrospectivos; Adenocarcinoma del Pulmón/genética; Adenocarcinoma del Pulmón/terapia; Inmunoterapia; Mutación; Proteína p53 Supresora de Tumor/genética

Palabras clave

Antibodies, Monoclonal; IMMUNOHISTOCHEMISTRY; Lung Neoplasms; ONCOGENES; Pathology Department, Hospital

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Pathol Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google